FIRSTFARMS A/S financials
FIRSTFARMS A/S
Country: DK Reporting currency: DKK Latest annual report: 2025-12-31
LEI:
2138007DFVFLUCCSX925 Financial statements
(DKK, as reported — unscaled; 93 line items across 2 annual periods)
| Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Revenue | DKK 379.2M | DKK 454.0M |
| Other income | DKK 39.3M | DKK 6.8M |
| Employee benefits expense | DKK 113.7M | DKK 112.1M |
| Raw materials & consumables used | DKK 224.2M | DKK 211.4M |
| Operating profit (EBIT) | DKK 12.7M | DKK 43.0M |
| Finance costs | DKK 35.8M | DKK 44.4M |
| Profit before tax | -DKK 18.7M | DKK 8.9M |
| Income tax expense | DKK 1.9M | -DKK 7.5M |
| Profit for the year | -DKK 20.6M | DKK 16.3M |
| Total comprehensive income | -DKK 13.6M | DKK 1.9M |
| Per share | ||
| Basic EPS | DKK -1.76 | DKK 1.55 |
| Diluted EPS | DKK -1.76 | DKK 1.55 |
| Free cash flow / share | DKK -11.39 | DKK -4.51 |
| Cash flow statement | ||
| Cash generated from operations | DKK 60.7M | DKK 88.7M |
| Net cash from operating activities | DKK 17.2M | DKK 47.1M |
| Income taxes paid | DKK 7.7M | DKK 7.7M |
| Net cash from investing activities | -DKK 141.4M | -DKK 89.4M |
| Purchase of PP&E (capex) | DKK 150.7M | DKK 94.6M |
| Net cash from financing activities | -DKK 1.5M | DKK 154.1M |
| Dividends paid | DKK 0 | DKK 0 |
| Proceeds from borrowings | DKK 78.0M | DKK 32.2M |
| Lease liability payments | DKK 14.9M | DKK 17.4M |
| Net change in cash | -DKK 125.6M | DKK 111.8M |
| Balance sheet | ||
| Total assets | DKK 1.74B | DKK 1.68B |
| Non-current assets | DKK 1.38B | DKK 1.27B |
| Intangible assets & goodwill | DKK 16.1M | DKK 16.1M |
| Current assets | DKK 367.0M | DKK 413.5M |
| Inventories | DKK 157.0M | DKK 118.3M |
| Trade & other receivables | DKK 23.4M | DKK 28.5M |
| Cash & equivalents | DKK 12.1M | DKK 137.7M |
| Total equity | DKK 899.3M | DKK 819.2M |
| — attributable to owners | DKK 898.5M | DKK 819.1M |
| Non-controlling interests | DKK 720.0K | DKK 60.0K |
| Non-current liabilities | DKK 675.4M | DKK 718.8M |
| Long-term borrowings | DKK 517.2M | DKK 514.6M |
| Current liabilities | DKK 170.2M | DKK 146.9M |
| Trade & other payables | DKK 57.2M | DKK 55.3M |
| Deferred tax liabilities | DKK 38.0M | DKK 40.9M |
| Derived metrics | ||
| Free cash flow | -DKK 133.5M | -DKK 47.5M |
| Operating margin | 3.3% | 9.5% |
| Net margin | -5.4% | 3.6% |
| Return on equity | -2.3% | 2.0% |
| Cash conversion ratio | -0.84× | 2.88× |
| Capex coverage | 0.11× | 0.50× |
| Other reported items | ||
| Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | DKK 66.5M | DKK 62.4M |
| Adjustments For Finance Costs | DKK 35.8M | DKK 44.4M |
| Adjustments For Finance Income | DKK 4.5M | DKK 10.3M |
| Adjustments For Gains Losses On Change In Fair Value Less Costs To Sell Biological Assets | -DKK 6.2M | -DKK 21.1M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | -DKK 2.7M | -DKK 4.0M |
| Adjustments For Sharebased Payments | DKK 1.2M | DKK 1.1M |
| Buildings | DKK 450.3M | DKK 400.1M |
| Cash Flows From Losing Control of Subsidiaries Or Other Businesses Classified As Investing Activities | DKK 0 | DKK 0 |
| Cash Flows From Used In Operations Before Changes In Working Capital | DKK 83.8M | DKK 123.5M |
| Construction In Progress | DKK 57.4M | DKK 39.9M |
| Current Biological Assets | DKK 128.8M | DKK 100.8M |
| Current Borrowings and Current Portion of Noncurrent Borrowings | DKK 108.0M | DKK 85.1M |
| Current Government Grants | DKK 4.5M | DKK 5.5M |
| Current Prepayments and Current Accrued Income Including Current Contract Assets | DKK 6.9M | DKK 10.5M |
| Current Tax Assets Current | DKK 5.9M | DKK 1.2M |
| Current Tax Liabilities Current | DKK 495.0K | DKK 946.0K |
| Deferred Tax Assets | DKK 17.2M | DKK 19.6M |
| Depreciation Amortisation and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | DKK 66.5M | DKK 62.4M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | DKK 0 | DKK 0 |
| Equity and Liabilities | DKK 1.74B | DKK 1.68B |
| Finance Income | DKK 4.5M | DKK 10.3M |
| Gains Losses On Fair Value Adjustment Biological Assets | -DKK 6.2M | -DKK 21.1M |
| Income Tax Relating To Components of Other Comprehensive Income | DKK 0 | DKK 0 |
| Increase Decrease In Working Capital | DKK 23.1M | DKK 34.8M |
| Interest Paid Classified As Operating Activities | DKK 35.8M | DKK 39.7M |
| Interest Received Classified As Operating Activities | -DKK 31.0K | DKK 5.8M |
| Issued Capital | DKK 122.5M | DKK 111.5M |
| Land | DKK 453.1M | DKK 440.9M |
| Liabilities | DKK 845.5M | DKK 865.7M |
| Noncurrent Biological Assets | DKK 56.7M | DKK 60.2M |
| Noncurrent Financial Assets At Fair Value Through Profit Or Loss | DKK 45.1M | DKK 45.1M |
| Noncurrent Government Grants | DKK 116.9M | DKK 70.2M |
| Other Comprehensive Income | DKK 7.0M | -DKK 14.4M |
| Other Comprehensive Income Attributable To Noncontrolling Interests | -DKK 660.0K | -DKK 60.0K |
| Other Comprehensive Income Before Tax Exchange Differences On Translation | DKK 7.7M | -DKK 14.4M |
| Other Current Receivables | DKK 32.9M | DKK 16.4M |
| Other Noncurrent Assets | DKK 62.3M | DKK 64.7M |
| Other Noncurrent Payables | DKK 3.3M | DKK 4.1M |
| Other Property Plant and Equipment | DKK 12.6M | DKK 13.3M |
| Payments To Acquire Or Redeem Entitys Shares | DKK 343.0K | DKK 8.6M |
| Proceeds From Exercise of Warrants | DKK 0 | DKK 5.6M |
| Proceeds From Issuing Shares | DKK 0 | DKK 96.9M |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | DKK 9.3M | DKK 5.2M |
| Property Plant and Equipment Including Rightofuse Assets | DKK 1.24B | DKK 1.13B |
| Purchase of Financial Instruments Classified As Investing Activities | DKK 0 | DKK 0 |
| Reserve of Exchange Differences On Translation | -DKK 41.2M | -DKK 48.9M |
| Retained Earnings | DKK 817.3M | DKK 756.5M |
| Revenue and Operating Income | DKK 499.3M | DKK 511.6M |
| Revenue From Government Grants | DKK 86.9M | DKK 71.9M |
Methodology
Every line item above is a fact tagged in FIRSTFARMS A/S's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (DKK), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.